Citation 5757

YOKOSUKA,A: SANO,T: HASHIMOTO,K: SAKAGAMI,H: MIMAKI,Y:. (2009). STEROIDAL GLYCOSIDES FROM FURCRAEA FOETIDA AND THEIR CYTOTOXIC ACTIVITY. 57(10)

Citation Details

TitleSTEROIDAL GLYCOSIDES FROM FURCRAEA FOETIDA AND THEIR CYTOTOXIC ACTIVITY
AuthorsYOKOSUKA,A: SANO,T: HASHIMOTO,K: SAKAGAMI,H: MIMAKI,Y:
Year2009
Volume57
Issue10

Summary

Year: 2009

Journal: Unknown

Organisms and Their Experiments (1)

Furcraea foetida (AGAVACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SPIROSTAN-3 BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-LUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:24(S)-25(S)-24-[(BETA-D-GLUCOPYRANOSYL)OXY]-5-ALPHA:SPIROSTAN-3-BETA-YL-BETA-D-FUCOPYRANOSIDE:23(S)-25(R)- 6-ALPHA-[(BETA-D--GLUCOPYRANOSYL)OXY]-23-HYDROXY-5- ALPHA:FUROSTAN-3-BETA-YL -O-BETA-D-GLUCOPYRANOSYL-(1 →3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-6-ALPHA-HYDROXY-22-ALPHA- -METHOXY-5-ALPHA:
None
2Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
SPIROSTAN-3-BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)- O-BETA-GLUCOPYRANOSYL-(1→2)-O-[O- ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-5-ALPHA:SPIROSTAN-3-BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-6-ALPHA-HYDROXY-5-ALPHA:SPIROSTAN-6-ALPHA-YL-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-3-BETA-D-23-DIHYDROXY-5-ALPHA:SPIROSTANE-3-BETA-D-6-ALPHA-DIYL BIS-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-23-HYDROXY-5-ALPHA:FUROSTAN-3-BETA-D-YL O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-22-ALPHA-METHOXY-5-ALPHA:FUROSTAN-12-ONE,25-(R)-3-BETA-D-[(O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSYL)OXY]-26-ALPHA-[(BETA-D-GLUCOPYRANOSYL)OXY]:FUROSTAN, 3-BETA-6-ALPHA-26-TRIYL TRIS-BETA-D-GLUCOPYRANOSIDE:25(R)-22-ALPHA-METHOXY-5-ALPHA:FURCREASTATIN
None
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3 BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-LUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:24(S)-25(S)-24-[(BETA-D-GLUCOPYRANOSYL)OXY]-5-ALPHA:SPIROSTAN-3-BETA-YL-BETA-D-FUCOPYRANOSIDE:23(S)-25(R)- 6-ALPHA-[(BETA-D--GLUCOPYRANOSYL)OXY]-23-HYDROXY-5- ALPHA:FUROSTAN-3-BETA-YL -O-BETA-D-GLUCOPYRANOSYL-(1 →3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-6-ALPHA-HYDROXY-22-ALPHA- -METHOXY-5-ALPHA:SPIROSTAN-3-BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-6-ALPHA-HYDROXY-5-ALPHA:SPIROSTAN-6-ALPHA-YL-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-3-BETA-D-23-DIHYDROXY-5-ALPHA:SPIROSTANE-3-BETA-D-6-ALPHA-DIYL BIS-BETA-D-GLUCOPYRANOSIDE:23(S)-25(R)-23-HYDROXY-5-ALPHA:FUROSTAN-3-BETA-D-YL O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-26-[(BETA-D-GLUCOPYRANOSYL)OXY]-22-ALPHA-METHOXY-5-ALPHA:FUROSTAN, 3-BETA-6-ALPHA-26-TRIYL TRIS-BETA-D-GLUCOPYRANOSIDE:25(R)-22-ALPHA-METHOXY-5-ALPHA:
INACTIVE
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROSTAN-3-BETA-YL-O-BETA-D-GLUCOPYRANOSYL-(1→3)- O-BETA-GLUCOPYRANOSYL-(1→2)-O-[O- ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSIDE:25(R)-5-ALPHA:FUROSTAN-12-ONE,25-(R)-3-BETA-D-[(O-BETA-D-GLUCOPYRANOSYL-(1→3)-O-BETA-D-GLUCOPYRANOSYL-(1→2)-O-[O-ALPHA-L-RHAMNOPYRANOSYL-(1→4)-BETA-D-GLUCOPYRANOSYL-(1→3)]-O-BETA-D-GLUCOPYRANOSYL-(1→4)-BETA-D-GALACTOPYRANOSYL)OXY]-26-ALPHA-[(BETA-D-GLUCOPYRANOSYL)OXY]:FURCREASTATIN
ACTIVE
Show SPARQL Queries (1)